Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Niger J Clin Pract ; 20(12): 1527-1530, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29378981

ABSTRACT

OBJECTIVES: The aim of this study was to evaluate the antimicrobial effects of diode laser and temperature rise on the root surface during application. MATERIALS AND METHODS: Thirty-six teeth were chemomechanically prepared and irrigated with 2.5% sodium hypochlorite and 17% ethylenediaminetetraacetic acid, and then autoclaved and incubated with a suspension of Enterococcus faecalis. The specimens were randomly divided into three groups (n = 12): Group 1, irradiated by diode laser at 1.2 W; Group 2, irradiated by diode laser at 2 W; and Group 3, irradiated by diode laser at 3 W. The grown bacteria were counted and the mean numbers of the each test tube were determined. The temperature was measured on the external apical third of the root during laser application. The mean values of results for each group were compared using one-way analysis of variance and Tukey test. RESULTS: No significant difference was obtained among the test groups in terms of the colony counts (P > 0.05). According to the temperature changes, there was a significant difference between groups (P < 0.05). Temperature rises were 16.79°C, 10.20°C, and 6.25°C in Group 3, Group 2, and Group 1, respectively. CONCLUSION: Diode laser irradiation with 1.2 W demonstrated comparable performance with 2 W and 3 W power sets for elimination of E. faecalis from root canal with less temperature rise.


Subject(s)
Anti-Bacterial Agents/pharmacology , Colony Count, Microbial , Dental Pulp Cavity/microbiology , Enterococcus faecalis/isolation & purification , Lasers, Semiconductor , Root Canal Therapy/methods , Tooth Root/drug effects , Tooth Root/radiation effects , Dentin , Edetic Acid , Humans , Root Canal Irrigants , Sodium Hypochlorite
2.
Benef Microbes ; 6(4): 415-21, 2015.
Article in English | MEDLINE | ID: mdl-25653151

ABSTRACT

Evidence from the literature has shown that Saccharomyces boulardii provides a clinically significant benefit in the treatment of acute infectious diarrhoea in children. In this multicentre, randomised, prospective, controlled, single blind clinical trial performed in children with acute watery diarrhoea, we aimed to evaluate the impact of S. boulardii CNCM I-745 in hospitalised children, in children requiring emergency care unit (ECU) stay and in outpatient settings. The primary endpoint was the duration of diarrhoea (in hours). Secondary outcome measures were duration of hospitalisation and diarrhoea at the 3(rd) day of intervention. In the whole study group (363 children), the duration of diarrhoea was approximately 24 h shorter in the S. boulardii group (75.4±33.1 vs 99.8±32.5 h, P<0.001). The effect of S. boulardii (diarrhoea-free children) was observed starting at 48 h. After 72 h, only 27.3% of the children receiving probiotic still had watery diarrhoea, in contrast to 48.5% in the control group (P<0.001). The duration of diarrhoea was significantly reduced in the probiotic group in hospital, ECU and outpatient settings (P<0.001, P<0.01 and P<0.001, respectively). The percentage of diarrhoea-free children was significantly larger after 48 and 72 h in all settings. The mean length of hospital stay was shorter with more than 36 h difference in the S. boulardii group (4.60±1.72 vs 6.12±1.71 days, P<0.001). The mean length of ECU stay was shorter with more than 19 h difference in the probiotic group (1.20±0.4 vs 2.0±0.3 days, P<0.001). No adverse effects related to the probiotic were noted. Because treatment can shorten the duration of diarrhoea and reduce the length of ECU and hospital stay, there is likely a social and economic benefit of S. boulardii CNCM I-745 in adjunction to oral rehydration solution in acute infectious gastroenteritis in children.


Subject(s)
Diarrhea/pathology , Diarrhea/therapy , Emergency Medical Services , Length of Stay , Probiotics/administration & dosage , Saccharomyces/physiology , Child, Preschool , Female , Humans , Infant , Male , Prospective Studies , Time Factors
3.
Biomed Res Int ; 2014: 519098, 2014.
Article in English | MEDLINE | ID: mdl-24995305

ABSTRACT

OBJECTIVE: The aim of this study was to evaluate alternative methods for the disinfection of denture-based materials. MATERIAL AND METHODS: Two different denture-based materials were included in the study. Before microbial test, the surface roughness of the acrylic resins was evaluated. Then, the specimens were divided into 8 experimental groups (n = 10), according to microorganism considered and disinfection methods used. The specimens were contaminated in vitro by standardized suspensions of Candida albicans ATCC#90028 and Candida albicans oral isolate. The following test agents were tested: sodium hypochlorite (NaOCl 1%), microwave (MW) energy, ultraviolet (UV) light, mouthwash containing propolis (MCP), Corega Tabs, 50% and 100% white vinegar. After the disinfection procedure, the number of remaining microbial cells was evaluated in CFU/mL. Kruskal-Wallis, ANOVA, and Dunn's test were used for multiple comparisons. Mann Whitney U test was used to compare the surface roughness. RESULTS: Statistically significant difference (P < 0.05) was found between autopolymerised and heat-cured acrylic resins. The autopolymerised acrylic resin surfaces were rougher than surfaces of heat-cured acrylic resin. The most effective disinfection method was 100% white vinegar for tested microorganisms and both acrylic resins. CONCLUSION: This study showed that white vinegar 100% was the most effective method for tested microorganisms. This agent is cost-effective and easy to access and thus may be appropriate for household use.


Subject(s)
Acrylic Resins/administration & dosage , Dentures/microbiology , Disinfectants/administration & dosage , Disinfection , Acrylic Resins/chemistry , Antifungal Agents/administration & dosage , Antifungal Agents/chemistry , Candida albicans/drug effects , Candida albicans/isolation & purification , Disinfectants/chemistry , Humans , In Vitro Techniques , Materials Testing , Surface Properties/drug effects
4.
Lett Appl Microbiol ; 57(5): 436-42, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23845113

ABSTRACT

The aim of this study is to predict potential hepatocellular damage by determining total antioxidant status (TAS) and matrix metalloproteinases (MMPs) 2 and 9 levels of different groups of dental surgery patients who are asymptomatic (normal alanine aminotransferase, aspartate aminotransferase records). Patients were divided into five groups according to the anamnesis [to be diagnosed formerly as hepatitis C virus (HCV) infection or not], microbiological (positive-anti-HCV antibodies and HCV RNA-positive or negative) and biochemical test results. Except for the control group, serum anti-HCV antibody levels and line immunoassay tests were found positive in all groups. HCV RNAs were found positive only in group 3 whom were formerly diagnosed with HCV infection, not under medical treatment and in group 5 under medical treatment (<2 × 10(5) IU ml(-1)). Statistical analyses were performed using one-way multifactorial anova (manova) at the statistical significance level of 5% and were confirmed that the changes in biochemical markers had significant effects on subjects who had been in different groups. Following multiple comparisons, significant groups' differences were obtained in all biochemical markers. In conclusion, to determine not only TAS levels but also the MMPs and evaluate those together may be noninvasive biomarkers for predicting the inflammation in liver and approaching the prognosis of HCV infection.


Subject(s)
Hepacivirus/isolation & purification , Hepatitis C/diagnosis , Hepatitis C/virology , Alanine Transaminase/blood , Aspartate Aminotransferases/blood , Hepatitis C/blood , Humans , Liver/pathology , Liver/virology , Matrix Metalloproteinase 2/blood , Matrix Metalloproteinase 9/blood
5.
Acta Anaesthesiol Scand ; 49(2): 177-82, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15715618

ABSTRACT

BACKGROUND: Bacterial translocation (BT) occurs after thermal injury and may result from an ischemic intestinal insult. The aim of the study was to investigate the effects of ketamine and propofol as anesthetic agents on BT in an animal model of burn injury. METHODS: Sixty male Wistar Albino rats were randomly assigned to six groups of 10 rats each. Anesthesia was induced and maintained with ketamine in groups 1, 2 and 3 and with propofol in groups 4, 5 and 6 during 6 h. Groups 2, 3, 5 and 6 received 30% total body surface area (TBSA) third-degree burns. Groups 1 and 4 had no burn injury. Then, they were allowed to recover from the anesthesia at the end of 6 h. Mean arterial pressure (MAP) was monitored continuously and maintained within 10% of baseline (before burn injury) levels in all animals. Animals in groups 3 and 6 had a laparotomy to obtain a tissue sample from the terminal ileum for determination of intestinal lipid peroxidation by-product malondialdehyde (MDA) before (baseline) and 6 and 24 h after burn injury (ABI). So these animals were not included in the BT studies. At postburn 24 h, animals in groups 1, 2 and 4, 5 were sacrified and samples were taken from the mesenteric lymph nodes (MLN), liver and spleen for bacteriologic cultures. RESULTS: The incidence of BT was found to be significantly higher in group 2 than in all the other groups. Bacterial translocation incidence of group 5 was not significantly different from that of groups 4 and 1. Group 5 was associated with a significantly reduced number of enteric organisms per gram of tissue compared to group 2. Baseline MDA contents of groups 3 and 6 were similar. Ileal MDA levels were increased in group 3, but there were no significant changes in group 6 at 6 and 24 h ABI compared to baseline. CONCLUSION: Our results suggest that propofol as an anesthetic agent may prevent BT by scavenging reactive oxygen species and inhibiting lipid peroxidation in an animal model of burn injury.


Subject(s)
Analgesics/therapeutic use , Anesthetics, Intravenous/therapeutic use , Bacterial Translocation/drug effects , Burns/metabolism , Ketamine/therapeutic use , Propofol/therapeutic use , Animals , Blood Pressure/physiology , Burns/therapy , Disease Models, Animal , Ileum/drug effects , Ileum/metabolism , Lipid Peroxidation/drug effects , Liver/microbiology , Lymph Nodes/microbiology , Male , Malondialdehyde/metabolism , Mesentery/microbiology , Rats , Rats, Wistar , Spleen/microbiology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...